From data and digital to precision medicine and genomics, we invest in technology, pharma/biotech and life sciences companies that improve healthcare outcomes.
Forepont Capital Partners accelerate medical innovations
through philanthropy and meaningful collaboration.
Forepont Capital Partners gives 10% of our Net Revenues and 10% of our time to non-profit medical research.